WallStreet Scope – November 18th 2015: Mid Day Changers
Intra-Cellular Therapies, Inc. (ITCI) of the Healthcare sector has changed by 3.48% and at noon is trading with a volume of 94,747 shares with a volatility this week of 7.00%. Intra-Cellular Therapies, Inc. (ITCI) currently stands at $51.19, with a weekly performance of -11.170% and a 52 week low of 263.31%. Intra-Cellular Therapies, Inc. (ITCI)’s monthly performance stands at 12.640% and Intra-Cellular Therapies, Inc. (ITCI) is considered a stock to watch with an analyst rating of 1.60
Canadian Solar Inc. (CSIQ) of the Technology sector (Semiconductor – Specialized) has a change of 3.46% per at mid-day today. Canadian Solar Inc. (CSIQ) is currently at $20.91, at a volume of 1,481,705 shares and a weekly performance of – 9.17%. Canadian Solar Inc. (CSIQ)’s monthly performance stands at – 7.04% and Canadian Solar Inc. (CSIQ) is considered a stock to watch with an analyst rating of 1.60
BioDelivery Sciences International, Inc. (BDSI) located in USA has gained 3.45% mid-day today. The return on investment for BioDelivery Sciences International, Inc. (BDSI) is trading at $5.69 with a weekly performance of – 6.940%. BioDelivery Sciences International, Inc. (BDSI)’S monthly performance stands at -19.35% and BioDelivery Sciences International, Inc. (BDSI) is volatile with volume of 285,819 shares, volatility of 6.45%, and an analyst rating of 1.70
Herbalife Ltd. (HLF) of the Consumer Goods sector located in Cayman Islands has gained 3.45%. Herbalife Ltd. (HLF) is at $56.310, a change of 3.450% with a weekly performance of – 1.340%. Herbalife Ltd. (HLF)’S monthly performance stands at – 2.590% and Herbalife Ltd. (HLF) is considered a stock to watch today has an analyst rating of 2.00
GenMark Diagnostics, Inc. (GNMK) of the Healthcare sector has gained 3.45% so far today. GenMark Diagnostics, Inc. (GNMK) currently sits at $7.200 with a weekly performance of – 9.260% and volatility of 7.47%. GenMark Diagnostics, Inc. (GNMK)’s monthly performance stands at -14.810% and GenMark Diagnostics, Inc. (GNMK) should be watched with an analyst rating of 1.70